These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 1729889)

  • 21. The Montreal platelet syndrome kindred has type 2B von Willebrand disease with the VWF V1316M mutation.
    Jackson SC; Sinclair GD; Cloutier S; Duan Z; Rand ML; Poon MC
    Blood; 2009 Apr; 113(14):3348-51. PubMed ID: 19060241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type 2M:Milwaukee-1 von Willebrand disease: an in-frame deletion in the Cys509-Cys695 loop of the von Willebrand factor A1 domain causes deficient binding of von Willebrand factor to platelets.
    Mancuso DJ; Kroner PA; Christopherson PA; Vokac EA; Gill JC; Montgomery RR
    Blood; 1996 Oct; 88(7):2559-68. PubMed ID: 8839848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a new type 2M von Willebrand disease mutation also at position 1324 of von Willebrand factor.
    Hilbert L; Fressinaud E; Ribba AS; Meyer D; Mazurier C;
    Thromb Haemost; 2002 Apr; 87(4):635-40. PubMed ID: 12008946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type IIB von Willebrand's disease: gene mutations and clinical presentation in nine families from Denmark, Germany and Sweden.
    Donnér M; Kristoffersson AC; Lenk H; Scheibel E; Dahlbäck B; Nilsson IM; Holmberg L
    Br J Haematol; 1992 Sep; 82(1):58-65. PubMed ID: 1419803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Von Willebrand's disease caused by compound heterozygosity for a substitution mutation (T1156M) in the D3 domain of the von Willebrand factor and a stop mutation (Q2470X).
    Lethagen S; Isaksson C; Schaedel C; Holmberg L
    Thromb Haemost; 2002 Sep; 88(3):421-6. PubMed ID: 12353070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib.
    Rabinowitz I; Tuley EA; Mancuso DJ; Randi AM; Firkin BG; Howard MA; Sadler JE
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9846-9. PubMed ID: 1409710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of two mutations (Arg611Cys and Arg611His) in the A1 loop of von Willebrand factor (vWF) responsible for type 2 von Willebrand disease with decreased platelet-dependent function of vWF.
    Hilbert L; Gaucher C; Mazurier C
    Blood; 1995 Aug; 86(3):1010-8. PubMed ID: 7620154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional analysis of a type IIB von Willebrand disease missense mutation: increased binding of large von Willebrand factor multimers to platelets.
    Cooney KA; Lyons SE; Ginsburg D
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2869-72. PubMed ID: 1557393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel mutation in the D3 domain of von Willebrand factor markedly decreases its ability to bind factor VIII and affects its multimerization.
    Jorieux S; Gaucher C; Goudemand J; Mazurier C
    Blood; 1998 Dec; 92(12):4663-70. PubMed ID: 9845532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and characterization of a novel mutation in von Willebrand factor causing type 2B von Willebrand's disease.
    Facey DA; Favaloro EJ; Koutts J; Berndt MC; Hertzberg MS
    Br J Haematol; 1999 May; 105(2):538-41. PubMed ID: 10233434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel candidate mutation (Arg611-->His) in type I 'platelet discordant' von Willebrand's disease with desmopressin-induced thrombocytopenia.
    Castaman G; Eikenboom JC; Rodeghiero F; Briët E; Reitsma PH
    Br J Haematol; 1995 Mar; 89(3):656-8. PubMed ID: 7734373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Arg545----Cys545 substitution mutation of the von Willebrand factor in type IIB von Willebrand's disease.
    Donnér M; Andersson AM; Kristoffersson AC; Nilsson IM; Dahlbäck B; Holmberg L
    Eur J Haematol; 1991 Nov; 47(5):342-5. PubMed ID: 1761120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New mutations in exon 28 of the von Willebrand factor gene detected in patients with different types of von Willebrand's disease.
    Casaña P; Martínez F; Haya S; Tavares A; Aznar JA
    Haematologica; 2001 Apr; 86(4):414-9. PubMed ID: 11325649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal binding of factor VIII is linked with the substitution of glutamine for arginine 91 in von Willebrand factor in a variant form of von Willebrand disease.
    Kroner PA; Friedman KD; Fahs SA; Scott JP; Montgomery RR
    J Biol Chem; 1991 Oct; 266(29):19146-9. PubMed ID: 1918030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease.
    Stepanian A; Ribba AS; Lavergne JM; Fressinaud E; Juhan-Vague I; Mazurier C; Girma JP; Meyer D
    Br J Haematol; 2003 Feb; 120(4):643-51. PubMed ID: 12588351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis of subtype 2B von Willebrand disease in a patient with 2A phenotype of plasma von Willebrand factor.
    Gaucher C; de Romeuf C; Rauïs-Morret M; Corazza F; Fondu P; Mazurier C
    Thromb Haemost; 1995 Apr; 73(4):610-6. PubMed ID: 7495067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA.
    Ginsburg D; Konkle BA; Gill JC; Montgomery RR; Bockenstedt PL; Johnson TA; Yang AY
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3723-7. PubMed ID: 2786201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the relationship of von Willebrand disease (vWD) and hereditary hemorrhagic telangiectasia and identification of a potential type IIA vWD mutation (IIe865 to Thr).
    Iannuzzi MC; Hidaka N; Boehnke M; Bruck ME; Hanna WT; Collins FS; Ginsburg D
    Am J Hum Genet; 1991 Apr; 48(4):757-63. PubMed ID: 1673047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substitution of cysteine for phenylalanine 751 in mature von Willebrand factor is a novel candidate mutation in a family with type IIA von Willebrand disease.
    Gaucher C; Hanss M; Dechavanne M; Mazurier C
    Br J Haematol; 1993 Jan; 83(1):94-9. PubMed ID: 8435341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The "Normandy" variant of von Willebrand disease: characterization of a point mutation in the von Willebrand factor gene.
    Gaucher C; Jorieux S; Mercier B; Oufkir D; Mazurier C
    Blood; 1991 May; 77(9):1937-41. PubMed ID: 2018834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.